bioAffinity Techn…
USUSDbioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 1. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par Uzņēmumu
- Tīmekļvietne
- bioaffinitytech.com
- Investoru Attiecības
- bioaffinitytech.com/contact/
- Nozare
- Health Care · Biotechnology: Commercial Physical & Biological Resarch
- Galvenā Mītne
- SAN ANTONIO, United States
- Izpilddirektors
- Maria Zannes
- Darbinieki
- 57
- Apgrozībā Esošās Akcijas
- 8.1 milj. uz 2026-08-03
- Brīvā Apgrozība
- 532 257
- Tirgus Kapitalizācija
- 3.69 milj. USD
- Iekšējās Personas
- 0.82%
- Institucionālie Investori
- 5.62%
- Nozare (SIC)
- Services-Commercial Physical & Biological Research
- P/E
- zaudējumi
- FCF
- −11.6 milj. USD
- Parāds
- 36.5 tūkst. USDneto nauda
- Peļņa un FCF — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
- NAV
Apraksts
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Biržas un Tikeri
| Birža | Tikeris | Valūta | Cena | Veids |
|---|---|---|---|---|
| US USA Stocks | BIAF | USD | 3.73 -5.81% | parastās akcijas |
Ziņas Šonedēļ
Preses relīzes no uzņēmuma investoru mājaslapas, kas tiek atjauninātas katru dienu. Saites ved uz uzņēmuma mājaslapu. Virsraksti ir oriģinālvalodā, kā uzņēmuma mājaslapā.
Lielākie Akcionāri
| Turētājs | Daļa | Akcijas | Pārskata Datums |
|---|---|---|---|
| ZANNES MARIA (Chief Exec… | ≈46.94% | 280 359 | 2025-01-10 |
| EDWARDS JAMES MICHAEL CP… | ≈20.11% | 120 128 | 2025-01-10 |
| ZANNES TIMOTHY PETER (Ge… | ≈9.17% | 54 765 | 2025-01-10 |
| REVELES XAVIER TRINIDAD… | ≈7.02% | 41 943 | 2025-01-10 |
| Sabby Management, LLC | 4.06% | 24 377 | 2026-06-30 |
| Blackrock Inc. | 1.1% | 6 585 | 2026-06-30 |
| Vanguard Capital Managem… | 0.62% | 3 703 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.62% | 3 703 | 2026-06-30 |
| Geode Capital Management… | 0.57% | 3 398 | 2026-06-30 |
| J. Safra Sarasin Holding… | 0.47% | 2 840 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.34% | 2 071 | 2026-06-30 |
| Susquehanna Internationa… | 0.3% | 1 791 | 2026-06-30 |
| Jane Street Group, LLC | 0.3% | 1 786 | 2026-06-30 |
| Fidelity Concord Street… | 0.28% | 1 659 | 2026-07-31 |
| State Street Corporation | 0.27% | 1 606 | 2026-06-30 |
| HRT Financial LP | 0.23% | 1 389 | 2026-06-30 |
| Fidelity Concord Street… | 0.08% | 509 | 2026-07-31 |
| Fidelity Concord Street… | 0.07% | 434 | 2026-07-31 |
| Fidelity Concord Street… | 0.03% | 167 | 2026-07-31 |
| GIRGENTI STEVEN (Officer… | — | 1.09 milj. | 2025-01-10 |
Pieslēdzies ar Google